To chelate or not to chelate in MDS: That is the question!
Author:
Funder
Genentech
Astex
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference92 articles.
1. NCCN task force: transfusion and iron overload in patients with myelodysplastic syndromes;Greenberg;J Natl Compr Canc Netw,2009
2. Iron overload and chelation therapy in myelodysplastic syndromes;Temraz;Crit Rev Oncol Hematol,2014
3. Serum iron metabolism and erythropoiesis in patients with myelodysplastic syndrome not receiving RBC transfusions;Cui;Leuk Res,2014
4. International scoring system for evaluating prognosis in myelodysplastic syndromes;Greenberg;Blood,1997
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Herramientas diagnóstico-terapéuticas en síndromes mielodisplásicos en Uruguay;Anales de la Facultad de Medicina;2023-04-01
2. Dysregulated Iron Homeostasis as Common Disease Etiology and Promising Therapeutic Target;Antioxidants;2023-03-09
3. How I Manage Transplant Ineligible Patients with Myelodysplastic Neoplasms;Clinical Hematology International;2022-12-27
4. From iron chelation to overload as a therapeutic strategy to induce ferroptosis in hematologic malignancies;Hematology;2022-10-12
5. Clinical view versus guideline adherence in ferritin monitoring and initiating iron chelation therapy in patients with myelodysplastic syndromes;European Journal of Haematology;2022-10-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3